Nusinersen (SpinrazaTM): The First FDA Approved Treatment for SMA
Prof. Adrian R. Krainer, PhD Cold Spring Harbor Laboratory 2017 Canada Gairdner Research Symposium October 27, 2017
▶︎
Therapeutic T cell engineering: CD19 CAR therapy and beyond
▶︎
Spinal Muscular Atrophy | Mechanism & Presentation
▶︎
Changing Landscape of Management in Eye Diseases
▶︎
Evoque Tricuspid Intervention:Jubin Joseph, MD
▶︎
Conan O’Brien Mocks Trump At Harvard Commencement | Crowd Erupts During Viral Speech
▶︎
STEM Talks - Brain Injury Awareness 2026
▶︎
SPINRAZA® (nusinersen) Mechanism of Action in Spinal Muscular Atrophy
▶︎
Gallium Maltoate for Brain Tumors
▶︎
Simple genetics for a complex disease: getting to the heart of the matter
▶︎
Critical Debate: Focal Therapy vs. Whole Gland Treatment for Prostate Cancer PGG 2/3
▶︎
Office Jazz ☕ Elegant Spring Coffee Jazz Music & Soft Bossa Nova Instrumental for Joyful Moods
▶︎
2019 ASAP Conference: Craniocervical Instability, P Bolognese
▶︎
STEM Talks - Nursing 2026
▶︎
Medical breakthroughs and health stories | 60 Minutes Marathon
▶︎
'Long COVID is a jaw-dropping lie': Doctor’s bombshell testimony ‘exposes’ mRNA vaccine ‘scandal’
▶︎
The Complex Relationship Between Atopic Dermatitis and Allergies
▶︎
ASH 2025 Comes to You! - with Adam Kittai, MD and Brian Koffman, MDCM (retired) MS Ed
▶︎
Salt Sugar Fat - Michael Moss
▶︎
Introduction to Neuroscience - Neurorehabilitation
▶︎